Kolexia
Salem Naji Oncologie radiothérapie
Salem Naji
Oncologie radiothérapie
Centre Paoli-Calmettes
Marseille, France
120 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de la prostate Carcinomes Néphrocarcinome Métastase tumorale Tumeurs du poumon Carcinome pulmonaire non à petites cellules Récidive tumorale locale Carcinome pulmonaire à petites cellules Carcinome épidermoïde

Collaborateurs

Voir plus
Gravis-Mescam Gwenaelle
Gravis-Mescam Gwenaelle
Centre Paoli-Calmettes, Marseille, France
Walz Jochen
Walz Jochen
Centre Paoli-Calmettes, Marseille, France
Brunelle Serge
Brunelle Serge
Centre Paoli-Calmettes, Marseille, France
Pignot Geraldine
Pignot Geraldine
Centre Paoli-Calmettes, Marseille, France

Industries

Voir plus
AstraZeneca
11 collaboration(s)
Dernière en 2022
Astellas
5 collaboration(s)
Dernière en 2022
B3TSI
2 collaboration(s)
Dernière en 2021
Ipsen
1 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
BLAD-RAD01: Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients Without Progression and With no More Than Three Residual Metastatic Lesions Following First Line Systemic Therapy: a Prospective Randomized Comparative Phase II Trial
Essai Clinique (Institut Universitaire du Cancer Toulouse Oncopole)   01 février 2024
A novel lung SBRT treatment planning: Inverse VMAT plan with leaf motion limitation to ensure the irradiation reproducibility of a moving target.
Medical dosimetry : official journal of the American Association of Medical Dosimetrists   06 décembre 2023
Prospective results for 5-year survival and toxicity of moderately hypofractionated radiotherapy with simultaneous integrated boost (SIB) in (very) high-risk prostate cancer.
Clinical and translational radiation oncology   17 novembre 2023
1291O Radiotherapy boost to 74 Gy based on FDG-PET at 42 Gy of radiochemotherapy (RCT) in patients with inoperable stage III non-small cell lung cancer (RTEP7 – IFCT 1401): A prospective multicentre, open-label, randomised, controlled trial
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
GETUG-StORM-01: A Randomized Phase II Study Assessing Stereotactic Radiotherapy in Therapeutic Strategy of Oligoprogressive Renal Cell Carcinoma Metastases
Essai Clinique (Centre François-Baclesse)   31 juillet 2023
The impact of brachytherapy boost for anal canal cancers in the era of de-escalation treatments.
Brachytherapy   06 mai 2023
Is MRI-Linac helpful in SABR treatments for liver cancer?
Frontiers in oncology   16 mars 2023
Impact of long-term indwelling JJ stent on renal volume and renal function.
Minerva urology and nephrology   16 novembre 2022
Impact of active surveillance for prostate cancer on the risk of depression and anxiety.
Scientific reports   28 juillet 2022
External validation of the computerized analysis of TRUS of the prostate with the ANNA/C-TRUS system: a potential role of artificial intelligence for improving prostate cancer detection.
World journal of urology   06 mars 2022